174 related articles for article (PubMed ID: 24182652)
21. The in vitro and in vivo investigation of inhaled migraine therapies using a novel aerosol delivery system consisting of an air pressurized capsule device (APCD) in combination with a pMDI spacer for endotracheal dosing into beagle dogs.
Sellers S; Horodnik W; House A; Wylie J; Mauser P; Garber N; Pu YE; Berry J; Donovan B
Drug Dev Ind Pharm; 2015; 41(12):1989-96. PubMed ID: 25986873
[TBL] [Abstract][Full Text] [Related]
22. Aerosol Use in the Pulmonary Function Lab.
Ruppel GL
Respir Care; 2015 Jun; 60(6):931-40; discussion 940. PubMed ID: 26070584
[TBL] [Abstract][Full Text] [Related]
23. Inhaled drugs and global warming: time to shift to dry powder inhalers.
Hillman T; Mortimer F; Hopkinson NS
BMJ; 2013 May; 346():f3359. PubMed ID: 23714412
[No Abstract] [Full Text] [Related]
24. Establishing standardised methods for comparing aqueous droplet inhalers.
Berg E; Svensson JO
Pharmeur Sci Notes; 2006 Dec; 2006(2):9-15. PubMed ID: 17691209
[TBL] [Abstract][Full Text] [Related]
25. Emerging inhalation aerosol devices and strategies: where are we headed?
Zhou QT; Tang P; Leung SS; Chan JG; Chan HK
Adv Drug Deliv Rev; 2014 Aug; 75():3-17. PubMed ID: 24732364
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic optimisation of asthma treatment.
Taburet AM; Schmit B
Clin Pharmacokinet; 1994 May; 26(5):396-418. PubMed ID: 7914480
[TBL] [Abstract][Full Text] [Related]
27. In vitro evaluation of dry powder inhaler devices of corticosteroid preparations.
Tamura G; Sakae H; Fujino S
Allergol Int; 2012 Mar; 61(1):149-54. PubMed ID: 22189592
[TBL] [Abstract][Full Text] [Related]
28. Superiority of nebulized corticosteroids over dry powder inhalers in certain patients with cough variant asthma or cough-predominant asthma.
Kamimura M; Izumi S; Hamamoto Y; Morita A; Toyota E; Kobayashi N; Kudo K
Allergol Int; 2012 Sep; 61(3):411-7. PubMed ID: 22627846
[TBL] [Abstract][Full Text] [Related]
29. Inhalation therapy with metered-dose inhalers and dry powder inhalers in mechanically ventilated patients.
Dhand R
Respir Care; 2005 Oct; 50(10):1331-4; discussion 1344-5. PubMed ID: 16185369
[TBL] [Abstract][Full Text] [Related]
30. Clinical Controversies in Aerosol Therapy for Infants and Children.
DiBlasi RM
Respir Care; 2015 Jun; 60(6):894-914; discussion 914-6. PubMed ID: 26070582
[TBL] [Abstract][Full Text] [Related]
31. Inhalation therapy in asthmatic and not asthmatic children.
Lo Valvo L; Leonardi S; Marseglia GL; Miraglia Del Giudice M; Salpietro C; Ciprandi G; La Rosa M
Int J Immunopathol Pharmacol; 2011 Oct; 24(4 Suppl):61-7. PubMed ID: 22032789
[TBL] [Abstract][Full Text] [Related]
32. [Inhalation devices: characteristics, modeling, regulation and use in routine practice. GAT Aerosolstorming, Paris 2011].
Ferré A; Dres M; Roche N; Antignac M; Becquemin MH; Trosini V; Vecellio L; Chantrel G; Dubus JC
Rev Mal Respir; 2012 Feb; 29(2):191-204. PubMed ID: 22405113
[TBL] [Abstract][Full Text] [Related]
33. The history, current state and perspectives of aerosol therapy.
Rospond B; Krakowska A; Muszyńska B; Opoka W
Acta Pharm; 2022 Jun; 72(2):225-243. PubMed ID: 36651510
[TBL] [Abstract][Full Text] [Related]
34. Aerosol Therapy in Pulmonary Critical Care.
Ari A
Respir Care; 2015 Jun; 60(6):858-74; discussion 874-9. PubMed ID: 26070580
[TBL] [Abstract][Full Text] [Related]
35. Aerosol therapy in the equine species.
Duvivier DH; Votion D; Vandenput S; Lekeux P
Vet J; 1997 Nov; 154(3):189-202. PubMed ID: 9414952
[TBL] [Abstract][Full Text] [Related]
36. Advances in inhalation therapy in pediatrics.
Muchão FP; Filho LV
J Pediatr (Rio J); 2010; 86(5):367-76. PubMed ID: 20938588
[TBL] [Abstract][Full Text] [Related]
37. A Review: The Prospect of Inhaled Insulin Therapy via Vibrating Mesh Technology to Treat Diabetes.
Cunningham SM; Tanner DA
Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32785196
[No Abstract] [Full Text] [Related]
38. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
Li X; Vogt FG; Hayes D; Mansour HM
Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736
[TBL] [Abstract][Full Text] [Related]
39. Dysphonia associated with the use of inhaled corticosteroids.
Chmielewska M; Akst LM
Curr Opin Otolaryngol Head Neck Surg; 2015 Jun; 23(3):255-9. PubMed ID: 25887975
[TBL] [Abstract][Full Text] [Related]
40. What is new in asthma: new dry powder inhalers.
Hannemann LA
J Pediatr Health Care; 1999; 13(4):159-65. PubMed ID: 10690079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
